AU6528494A - Nitric oxide combination therapy - Google Patents

Nitric oxide combination therapy

Info

Publication number
AU6528494A
AU6528494A AU65284/94A AU6528494A AU6528494A AU 6528494 A AU6528494 A AU 6528494A AU 65284/94 A AU65284/94 A AU 65284/94A AU 6528494 A AU6528494 A AU 6528494A AU 6528494 A AU6528494 A AU 6528494A
Authority
AU
Australia
Prior art keywords
nitric oxide
combination therapy
oxide combination
therapy
nitric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65284/94A
Inventor
Jonathan S Stamler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Publication of AU6528494A publication Critical patent/AU6528494A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU65284/94A 1993-04-06 1994-03-31 Nitric oxide combination therapy Abandoned AU6528494A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4436793A 1993-04-06 1993-04-06
US044367 1993-04-06
PCT/US1994/003562 WO1994022306A1 (en) 1993-04-06 1994-03-31 Nitric oxide combination therapy

Publications (1)

Publication Number Publication Date
AU6528494A true AU6528494A (en) 1994-10-24

Family

ID=21931992

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65284/94A Abandoned AU6528494A (en) 1993-04-06 1994-03-31 Nitric oxide combination therapy

Country Status (2)

Country Link
AU (1) AU6528494A (en)
WO (1) WO1994022306A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627738B2 (en) 1995-09-15 2003-09-30 Duke University No-modified hemoglobins and uses therefor
US6197745B1 (en) 1995-09-15 2001-03-06 Duke University Methods for producing nitrosated hemoglobins and therapeutic uses therefor
US6153186A (en) 1995-09-15 2000-11-28 Duke University Medical Center Red blood cells loaded with S-nitrosothiol and uses therefor
US6855691B1 (en) 1995-09-15 2005-02-15 Duke University Methods for producing and using S-nitrosohemoglobins
US6916471B2 (en) 1995-09-15 2005-07-12 Duke University Red blood cells loaded with S-nitrosothiol and uses therefor
US6911427B1 (en) 1995-09-15 2005-06-28 Duke University No-modified hemoglobins and uses therefore
US6232434B1 (en) 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US6171232B1 (en) * 1997-06-26 2001-01-09 Cordis Corporation Method for targeting in vivo nitric oxide release
US6601580B1 (en) 2000-06-28 2003-08-05 The General Hospital Corporation Enhancing therapeutic effectiveness of nitric oxide inhalation
US11291637B2 (en) 2016-09-16 2022-04-05 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Methods for treating or preventing organophosphate poisoning
WO2023173141A2 (en) * 2022-03-11 2023-09-14 Loma Linda University Compositions and methods of treatment of disease using combination of a nitrodilator and a nitrogen oxide compound

Also Published As

Publication number Publication date
WO1994022306A1 (en) 1994-10-13

Similar Documents

Publication Publication Date Title
AU7819994A (en) Nitric oxide treatment
AU696232B2 (en) Syringe
AU7158694A (en) External fixation dressing
AU7637694A (en) Controlled multi-pharmaceutical inhaler
AU7516194A (en) Wound treatment
GB9324250D0 (en) Inhaler
AU6088394A (en) Multi-wire multi-balloon catheter
AU1072695A (en) Dressing
AU7678496A (en) Combinational therapeutic methods employing nitric oxide scavengers
AU7085594A (en) Syringe
AU7045194A (en) Compounds which release nitric oxide
AU683237B2 (en) Semiclosed respirator
GB2280557B (en) Defibrillator
GB9312197D0 (en) Inhaler
AU7220794A (en) Detergent-package combination
AU7820494A (en) Tin oxide
AU6528494A (en) Nitric oxide combination therapy
AU1480497A (en) Cancer treatment
AU4032793A (en) Nitric oxide sensor
AU4685893A (en) Nitric oxide-specific electrode
AU7227494A (en) Inhalator
GB9307013D0 (en) Therapeutic combinations
AU1292995A (en) Bis-oxazolidine compounds and their use
GB9317146D0 (en) Therapeutic combinations
AU6654494A (en) Safety devices